CODX vs WST · rev $3.9M vs P/E 35, rev $2.89B
Co-Diagnostics, Inc. Common Stock (CODX) versus West Pharmaceutical Services Inc (WST) — a side-by-side from cached financials, not a winner call.
Co-Diagnostics, Inc. Common Stock (CODX) is a medical devices company listed on US.
West Pharmaceutical Services Inc (WST) is a medical instruments & supplies company listed on US.
Latest reported CODX revenue for 2024-12-31 was $3.9M. Net income was -$37.6M. Revenue was down 42.5% from 2023-12-31 to 2024-12-31. CODX currently screens at market cap $31.4M.
Latest reported WST revenue for 2024-12-31 was $2.89B. Net income was $492.7M. Revenue was down 1.9% from 2023-12-31 to 2024-12-31. WST currently screens at market cap $15.97B and trailing P/E 34.8.
CODX currently screens at market cap $31.4M. WST currently screens at market cap $15.97B and trailing P/E 34.8.
Not investment advice. Open the CODX and WST stock pages for the full models.
Not investment advice.